JP2020527727A5 - - Google Patents

Download PDF

Info

Publication number
JP2020527727A5
JP2020527727A5 JP2020522785A JP2020522785A JP2020527727A5 JP 2020527727 A5 JP2020527727 A5 JP 2020527727A5 JP 2020522785 A JP2020522785 A JP 2020522785A JP 2020522785 A JP2020522785 A JP 2020522785A JP 2020527727 A5 JP2020527727 A5 JP 2020527727A5
Authority
JP
Japan
Prior art keywords
binding molecule
seq
diagnostic method
cell receptor
autonomously
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020522785A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020527727A (ja
JP7239575B2 (ja
Filing date
Publication date
Priority claimed from EP18162666.4A external-priority patent/EP3424527A1/de
Application filed filed Critical
Publication of JP2020527727A publication Critical patent/JP2020527727A/ja
Publication of JP2020527727A5 publication Critical patent/JP2020527727A5/ja
Application granted granted Critical
Publication of JP7239575B2 publication Critical patent/JP7239575B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020522785A 2017-07-07 2018-07-05 サンプル中の自律的に活性なb細胞受容体または自律的に活性化されたb細胞受容体を認識する方法 Active JP7239575B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP17001167 2017-07-07
EP17001167.0 2017-07-07
EP17001166.2 2017-07-07
EP17001166 2017-07-07
EP18162666.4 2018-03-19
EP18162666.4A EP3424527A1 (de) 2017-07-07 2018-03-19 Diagnostisches verfahren
PCT/EP2018/068316 WO2019008128A1 (de) 2017-07-07 2018-07-05 Diagnostisches verfahren

Publications (3)

Publication Number Publication Date
JP2020527727A JP2020527727A (ja) 2020-09-10
JP2020527727A5 true JP2020527727A5 (cg-RX-API-DMAC7.html) 2021-08-12
JP7239575B2 JP7239575B2 (ja) 2023-03-14

Family

ID=64500047

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020522785A Active JP7239575B2 (ja) 2017-07-07 2018-07-05 サンプル中の自律的に活性なb細胞受容体または自律的に活性化されたb細胞受容体を認識する方法
JP2020522786A Active JP7271532B2 (ja) 2017-07-07 2018-07-05 生物学的結合分子

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020522786A Active JP7271532B2 (ja) 2017-07-07 2018-07-05 生物学的結合分子

Country Status (5)

Country Link
US (2) US11634487B2 (cg-RX-API-DMAC7.html)
EP (4) EP3424528A1 (cg-RX-API-DMAC7.html)
JP (2) JP7239575B2 (cg-RX-API-DMAC7.html)
CA (1) CA3070848A1 (cg-RX-API-DMAC7.html)
WO (2) WO2019008129A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3424528A1 (de) * 2017-07-07 2019-01-09 AVA Lifescience GmbH Biologische bindemoleküle
WO2020221463A1 (de) * 2019-05-02 2020-11-05 Ava Lifescience Gmbh Verfahren zur selektion biologischer bindemoleküle
EP3733709A1 (de) * 2019-05-02 2020-11-04 AVA Lifescience Biologische bindemoleküle
US12698325B2 (en) * 2019-05-02 2026-08-04 Ava Lifescience Gmbh Biological binding molecules
EP4387990A4 (en) * 2021-08-18 2025-07-30 Univ Pennsylvania COMPOSITIONS AND METHODS FOR CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR B CELL RECEPTORS
WO2023152204A1 (en) 2022-02-10 2023-08-17 Ava Lifescience Gmbh Antibodies targeting the b-cell receptor of chronic lymphocytic leukemia (cll) for use in treatment of cll
EP4227321A1 (en) * 2022-02-10 2023-08-16 AVA Lifescience GmbH Antibodies targeting the b-cell receptor of chronic lymphocytic leukemia (cll) for use in treatment of cll
CA3262006A1 (en) * 2022-07-25 2024-02-01 Sinabiosolution Gmbh Humanized chimeric antigen receptors targeting the B-lymphocyte receptor in chronic lymphocytic leukemia and their uses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7393531B2 (en) 2003-01-21 2008-07-01 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of MCSP
RU2691698C2 (ru) 2012-02-24 2019-06-17 ЭББВИ СТЕМСЕНТРКС ЭлЭлСи Антитела против sez6 и способы их применения
WO2014179714A1 (en) * 2013-05-03 2014-11-06 The Board Of Regents Of The University Of Texas System Generating peptoid vaccines
JP2016531915A (ja) * 2013-08-28 2016-10-13 ステムセントリックス, インコーポレイテッド 部位特異的抗体コンジュゲーション方法および組成物
EP3424528A1 (de) * 2017-07-07 2019-01-09 AVA Lifescience GmbH Biologische bindemoleküle

Similar Documents

Publication Publication Date Title
JP2020526590A5 (cg-RX-API-DMAC7.html)
RU2014114172A (ru) Легковыделяемые биспецифические антитела с природным иммуноглобулиновым форматом
JP2020018311A5 (cg-RX-API-DMAC7.html)
JP2021525546A5 (cg-RX-API-DMAC7.html)
JP2023538891A5 (cg-RX-API-DMAC7.html)
JP2016505634A5 (cg-RX-API-DMAC7.html)
JP5941615B2 (ja) ヒトcxcl1タンパク質の免疫学的測定方法
RU2010148904A (ru) Антитела к интерлейкину-1альфа и способы применения
RU2013111533A (ru) Способы получения мультиспецифичных и мультивалентных антител
AR126759A2 (es) Anticuerpos anti-ly6g6d y métodos de uso
RU2015126533A (ru) Анти-cd47 антитела и способы их применения
JP2021524275A5 (cg-RX-API-DMAC7.html)
PE20070183A1 (es) Anticuerpos monoclonales anti-trkb
JP2016512034A5 (cg-RX-API-DMAC7.html)
IL273196B2 (en) Claudin6 antibodies and methods of treating cancer
JP2015519055A5 (cg-RX-API-DMAC7.html)
RU2018119366A (ru) Мыши с гуманизированной легкой цепью
JP2019523651A5 (cg-RX-API-DMAC7.html)
RU2018128414A (ru) Новое psma-связывающее антитело и его применения
JP2011510654A5 (cg-RX-API-DMAC7.html)
RU2018137419A (ru) Связывающиеся с cd38 и pd-l1 молекулы
JP2018505681A5 (cg-RX-API-DMAC7.html)
JP2020532572A5 (cg-RX-API-DMAC7.html)
JP2013509878A5 (cg-RX-API-DMAC7.html)
WO2019235915A8 (en) Methods and means for attracting immune effector cells to tumor cells